CytoDyn (CYDY) Shares Issued (2011 - 2026)
CytoDyn's (CYDY) quarterly Shares Issued came in at $31.3 million in Q1 2026, down 16.19% YoY from $37.4 million in Q1 2025, and down 18.58% on a QoQ basis from $38.5 million in Q4 2025.
CytoDyn (CYDY) Shares Issued (2011 - 2026) Analysis & Trends
CytoDyn (CYDY) has 14 years of Shares Issued data on file, last reported at $31.3 million in Q1 2026.
- Quarterly Shares Issued fell 16.19% year-over-year to $31.3 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $31.3 million (down 16.19% YoY) and the FY2025 annual result came in at $38.3 million, up 48.26% from the prior year.
- Shares Issued retreated to $31.3 million in Q1 2026, from $38.5 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $38.5 million in Q3 2025 to a low of $10.3 million in Q1 2022.
- A 5-year average of $25.9 million and a median of $24.4 million in 2024 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2023 — Shares Issued plunged 39.82% — and 2024, when it surged 164.14%.
- Tracing CYDY's Shares Issued over 5 years: stood at $22.0 million in 2022, then slumped by 35.51% to $14.2 million in 2023, then jumped by 164.14% to $37.5 million in 2024, then grew by 2.66% to $38.5 million in 2025, then retreated by 18.58% to $31.3 million in 2026.
- The last three Shares Issued figures came in at $31.3 million (Q1 2026), $38.5 million (Q4 2025), and $38.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | CytoDyn | 258.01 Mn | 258.01 Mn | - | 31.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 31.32 Mn |
| Feb 28, 2026 | 31.32 Mn |
| Nov 30, 2025 | 38.47 Mn |
| Nov 30, 2025 | 38.47 Mn |
| Aug 31, 2025 | 38.47 Mn |
| Aug 31, 2025 | 38.47 Mn |
| May 31, 2025 | 38.32 Mn |
| May 31, 2025 | 38.32 Mn |
| Feb 28, 2025 | 37.37 Mn |
| Feb 28, 2025 | 37.37 Mn |
| Nov 30, 2024 | 37.47 Mn |
| Nov 30, 2024 | 37.47 Mn |
| Aug 31, 2024 | 25.80 Mn |
| Aug 31, 2024 | 25.80 Mn |
| May 31, 2024 | 25.85 Mn |
| May 31, 2024 | 25.85 Mn |
| Feb 29, 2024 | 22.95 Mn |
| Feb 29, 2024 | 22.95 Mn |
| Nov 30, 2023 | 14.19 Mn |
| Nov 30, 2023 | 14.19 Mn |